Craig Gracey Sells 2,083 Shares of Omada Health (NASDAQ:OMDA) Stock

Omada Health, Inc. (NASDAQ:OMDA) CAO Craig Gracey sold 2,083 shares of the business’s stock in a transaction on Monday, June 29th. The shares were sold at an average price of $21.00, for a total transaction of $43,743.00. Following the transaction, the chief accounting officer owned 858 shares of the company’s stock, valued at $18,018. This represents a 70.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Craig Gracey also recently made the following trade(s):

• On Friday, June 26th, Craig Gracey sold 2,084 shares of Omada Health stock. The stock was sold at an average price of $20.00, for a total value of $41,680.00.
• On Wednesday, June 24th, Craig Gracey sold 2,083 shares of Omada Health stock. The shares were sold at an average price of $19.01, for a total value of $39,597.83.
• On Monday, June 22nd, Craig Gracey sold 2,083 shares of Omada Health stock. The shares were sold at an average price of $18.00, for a total value of $37,494.00.
• On Friday, June 12th, Craig Gracey sold 6,894 shares of Omada Health stock. The stock was sold at an average price of $17.42, for a total value of $120,093.48.

Omada Health Stock Up 3.1%

Omada Health stock opened at $22.62 on Thursday. The firm has a market cap of $1.34 billion and a price-to-earnings ratio of -83.78. Omada Health, Inc. has a 52 week low of $10.28 and a 52 week high of $26.92. The business’s 50-day moving average price is $17.00 and its 200 day moving average price is $14.98.

Omada Health (NASDAQ:OMDA) last announced its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.03. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%.The company had revenue of $78.05 million during the quarter. Equities analysts expect that Omada Health, Inc. will post -0.01 EPS for the current year.

Institutional Investors Weigh In On Omada Health

Large investors have recently bought and sold shares of the company. Perceptive Advisors LLC purchased a new position in shares of Omada Health in the second quarter valued at approximately $44,402,000. Millennium Management LLC lifted its holdings in Omada Health by 1,195.0% in the 4th quarter. Millennium Management LLC now owns 2,272,168 shares of the company’s stock valued at $35,855,000 after purchasing an additional 2,096,705 shares in the last quarter. Loomis Sayles & Co. L P grew its holdings in shares of Omada Health by 23.0% during the fourth quarter. Loomis Sayles & Co. L P now owns 1,855,721 shares of the company’s stock worth $29,283,000 after buying an additional 346,588 shares in the last quarter. Divisadero Street Capital Management LP acquired a new stake in shares of Omada Health in the third quarter valued at about $30,510,000. Finally, Jefferies Financial Group Inc. acquired a new position in Omada Health during the fourth quarter worth about $16,948,000.

Analyst Upgrades and Downgrades

Several analysts recently commented on OMDA shares. JPMorgan Chase & Co. dropped their price target on shares of Omada Health from $32.00 to $26.00 and set an “overweight” rating on the stock in a research report on Thursday, March 12th. Evercore reiterated an “outperform” rating and issued a $20.00 price objective on shares of Omada Health in a research report on Friday, May 8th. Wall Street Zen raised shares of Omada Health from a “hold” rating to a “buy” rating in a research note on Saturday, June 27th. BMO Capital Markets cut their price target on Omada Health from $27.00 to $18.00 and set an “outperform” rating for the company in a research note on Friday, March 6th. Finally, The Goldman Sachs Group restated a “buy” rating on shares of Omada Health in a research note on Friday, May 8th. Ten research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Omada Health presently has an average rating of “Moderate Buy” and a consensus price target of $22.91.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.